Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with

Masahiro Sakai1, Toshinori Hirai2,3, Satoshi Shitara2

  • 1The Jikei University School of Medicine, Tokyo, Japan.

Insights

The Modification of Diet in Renal Disease (MDRD) equation is best for adjusting digoxin doses in atrial fibrillation (AF) and heart failure (HF) patients based on kidney function. This helps maintain safe serum digoxin trough concentrations.

Area of Science:

  • Pharmacology
  • Nephrology
  • Cardiology

Background:

  • Digoxin is crucial for managing atrial fibrillation (AF) and heart failure (HF).
  • Accurate renal function estimation is vital for safe digoxin dosing to avoid toxicity.
  • Existing equations for estimating glomerular filtration rate (eGFR) may vary in their suitability for digoxin dose adjustment.

Purpose of the Study:

  • To identify the most appropriate equation for estimating renal function to guide digoxin dosing in patients with AF and HF.
  • To achieve a target serum digoxin trough concentration below 0.9 ng/ml.

Main Methods:

  • Patients with AF and HF received a daily oral dose of 0.125 mg digoxin.
  • Renal function was estimated using the Modification of Diet in Renal Disease (eGFRMDRD) and Chronic Kidney Disease Epidemiology Collaboration (eGFRCKD-EPI) equations, as well as the Cockcroft-Gault equation.
  • Deindexed eGFR values based on body surface area were correlated with serum digoxin trough concentrations.

Main Results:

  • The deindexed eGFRMDRD equation showed the highest correlation with digoxin trough concentrations (r = -0.450).
  • Median digoxin trough concentrations increased with declining renal function, ranging from 0.60 ng/ml (eGFRMDRD ≥ 60 ml/min) to 1.30 ng/ml (eGFRMDRD < 30 ml/min).

Conclusions:

  • The deindexed eGFRMDRD equation is suitable for digoxin dose adjustment in patients with AF and HF.
  • Using eGFRMDRD can help optimize digoxin therapy and maintain therapeutic concentrations.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
128
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
132
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
443
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
180
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
211
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
665